Endoscopic Retrograde Cholangiopancreatography for Ampullary Carcinomas: Friend or Foe?

Anargyros Bakopoulos; Nikolaos Koliakos; Dimitrios Schizas; Diamantis I Tsilimigras; Maria Syriga; Dimitrios Moris; Nikolaos Machairas; Vasileia Ntomi; Anastasios Machairas; Stavros Angelis; Alexandros P Apostolopoulos; Angelos Nikolaou; Dimitrios K Filippou

doi:10.1615/JLongTermEffMedImplants.2020034107

Endoscopic Retrograde Cholangiopancreatography for Ampullary Carcinomas: Friend or Foe?

J Long Term Eff Med Implants. 2019;29(4):277-280. doi: 10.1615/JLongTermEffMedImplants.2020034107.

Affiliations

¹ Third Department of Surgery, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece.
² First Department of Surgery, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece.
³ Anatomy Department, Medical School, National and Kapodistrian University of Athens, Greece; Trauma and Orthopaedic Department, "Korgialenio-Benakio" Hellenic Red Cross Hospital, Athens, Greece.
⁴ Trauma and Orthopaedic Department, "Korgialenio-Benakio" Hellenic Red Cross Hospital, Athens, Greece; Trauma and Orthopaedic Department, Ealing Hospital, North West University Healthcare NHS Trust, London, United Kingdom.
⁵ Anatomy Department, Medical School, National and Kapodistrian University of Athens, Greece.
⁶ Department of Anatomy and Surgical Anatomy, Medical School, National and Kapodestrian University of Athens, Athens, GRC.

PMID: 32749131
DOI: 10.1615/JLongTermEffMedImplants.2020034107

Abstract

The role of preoperative endoscopic retrograde cholangiopancreatography (ERCP) in ampullary carcinomas is under debate due to potential associated complications. We report the case of a 59-year-old male diagnosed with ampullary cancer, who had undergone ERCP that was followed by bleeding and perforation. We conclude that interventions before surgical resection, including ERCP, may compromise patient outcome.